Pharmacoeconomic Analysis of Using Biological Agents in the Treatment of Rheumatoid Arthritis

Modern Rheumatology Journal
doi 10.14412/1996-7012-2014-3-82-88
Full Text
Abstract

Available in full text

Date
Authors
Publisher

IMA Press, LLC

Related search

Efficacy of Biological Agents Administered as Monotherapy in Rheumatoid Arthritis: A Bayesian Mixed-Treatment Comparison Analysis

Therapeutics and Clinical Risk Management
2015English

Rheumatoid Arthritis Therapy With Genetically Engineered Biological Agents in the Republic of Karelia

Modern Rheumatology Journal
2013English

Pharmacoeconomic Analysis of Using Biological Agents for Uncontrolled Moderate-To-Severe Atopic Asthma in the Russian Federation

FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology
2020English

Persistence With Biologic Agents for the Treatment of Rheumatoid Arthritis in Japan

Patient Preference and Adherence
PharmacologyHealth PolicyMedicineToxicologySocial SciencesPharmaceutics
2016English

The Treatment of Rheumatoid Arthritis.

JAMA - Journal of the American Medical Association
Medicine
1929English

Inhibitor of Biological Effects of Interleukin-6 Sarilumab in Treatment of Rheumatoid Arthritis

Medical Council
2019English

Use of Biologic Agents in the Treatment of Rheumatoid Arthritis: An Analysis of the Quebec Provincial Drug Reimbursement Program Database

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Treatment of Rheumatoid Arthritis

Rheumatology
RheumatologyPharmacology
1997English

Treatment of Rheumatoid Arthritis

1981English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy